{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:09:07Z","timestamp":1784365747133,"version":"3.55.0"},"reference-count":48,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.2967\/jnumed.122.264404","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T22:35:16Z","timestamp":1663281316000},"page":"460-465","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of Tau Radiotracers in Chronic Traumatic Encephalopathy"],"prefix":"10.2967","volume":"64","author":[{"given":"Cassis","family":"Varlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Vasdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"2023033021451397000_64.3.460.1","doi-asserted-by":"crossref","unstructured":"Banks SJ . Chronic traumatic encephalopathy (CTE). In: Tousi B Cummings J , eds. Neuro-Geriatrics: A Clinical Manual. Springer International Publishing; 2017:183\u2013194.","DOI":"10.1007\/978-3-319-56484-5_13"},{"key":"2023033021451397000_64.3.460.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1515-z"},{"key":"2023033021451397000_64.3.460.3","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlab001"},{"key":"2023033021451397000_64.3.460.4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-014-0068-z","article-title":"Clinical subtypes of chronic traumatic encephalopathy: literature review and proposed research diagnostic criteria for traumatic encephalopathy syndrome","volume":"6","author":"Montenigro","year":"2014","journal-title":"Alzheimers Res Ther."},{"key":"2023033021451397000_64.3.460.5","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1093\/neuros\/nyab138","article-title":"Letter: recommendation to create new neuropathologic guidelines for the post-mortem diagnosis of chronic traumatic encephalopathy","volume":"89","author":"Omalu","year":"2021","journal-title":"Neurosurgery."},{"key":"2023033021451397000_64.3.460.6","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/alz.12338","article-title":"Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology","volume":"17","author":"Mez","year":"2021","journal-title":"Alzheimers Dement."},{"key":"2023033021451397000_64.3.460.7","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-015-0522-z"},{"key":"2023033021451397000_64.3.460.8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3389\/fneur.2019.00831","article-title":"[18F]FDG, [11C]PiB, and [18F]AV-1451 PET imaging of neurodegeneration in two subjects with a history of repetitive trauma and cognitive decline","volume":"10","author":"Okonkwo","year":"2019","journal-title":"Front Neurol."},{"key":"2023033021451397000_64.3.460.9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/jamaneurol.2019.4509","article-title":"Tau positron emission tomographic findings in a former US football player with pathologically confirmed chronic traumatic encephalopathy","volume":"77","author":"Mantyh","year":"2020","journal-title":"JAMA Neurol."},{"key":"2023033021451397000_64.3.460.10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1409952112"},{"key":"2023033021451397000_64.3.460.11","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/tp.2014.91","article-title":"Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury","volume":"4","author":"Mitsis","year":"2014","journal-title":"Transl Psychiatry."},{"key":"2023033021451397000_64.3.460.12","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1038\/tp.2016.175","article-title":"Cerebral [18F]T807\/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy","volume":"6","author":"Dickstein","year":"2016","journal-title":"Transl Psychiatry."},{"key":"2023033021451397000_64.3.460.13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40478-019-0686-6","article-title":"Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue","volume":"7","author":"Aguero","year":"2019","journal-title":"Acta Neuropathol Commun."},{"key":"2023033021451397000_64.3.460.14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-019-0808-1","article-title":"[18F]-AV-1451 binding profile in chronic traumatic encephalopathy: a postmortem case series","volume":"7","author":"Marqui\u00e9","year":"2019","journal-title":"Acta Neuropathol Commun."},{"key":"2023033021451397000_64.3.460.15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/neuros\/nyx536","article-title":"Postmortem autopsy-confirmation of antemortem [F-18]FDDNP-PET scans in a football player with chronic traumatic encephalopathy","volume":"82","author":"Omalu","year":"2018","journal-title":"Neurosurgery."},{"key":"2023033021451397000_64.3.460.16","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1093\/brain\/awz238","article-title":"PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury","volume":"142","author":"Takahata","year":"2019","journal-title":"Brain."},{"key":"2023033021451397000_64.3.460.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2012.11.019"},{"key":"2023033021451397000_64.3.460.18","doi-asserted-by":"crossref","first-page":"598980","DOI":"10.3389\/fneur.2020.598980","article-title":"Case report: 18F-MK6240 tau positron emission tomography pattern resembling chronic traumatic encephalopathy in a retired Australian Rules football player","volume":"11","author":"Krishnadas","year":"2020","journal-title":"Front Neurol."},{"key":"2023033021451397000_64.3.460.19","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1056\/NEJMoa1900757","article-title":"Tau positron-emission tomography in former National Football League players","volume":"380","author":"Stern","year":"2019","journal-title":"N Engl J Med."},{"key":"2023033021451397000_64.3.460.20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw8434"},{"key":"2023033021451397000_64.3.460.21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nicl.2019.101651","article-title":"Positron emission tomography of tau in Iraq and Afghanistan veterans with blast neurotrauma","volume":"21","author":"Robinson","year":"2019","journal-title":"Neuroimage Clin."},{"key":"2023033021451397000_64.3.460.22","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1089\/neu.2018.6178","article-title":"Multi-modal signatures of tau pathology, neuronal fiber integrity, and functional connectivity in traumatic brain injury","volume":"36","author":"Wooten","year":"2019","journal-title":"J Neurotrauma."},{"key":"2023033021451397000_64.3.460.23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nicl.2019.102025","article-title":"Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy","volume":"24","author":"Lesman-Segev","year":"2019","journal-title":"Neuroimage Clin."},{"key":"2023033021451397000_64.3.460.24","doi-asserted-by":"crossref","first-page":"102665","DOI":"10.1016\/j.nicl.2021.102665","article-title":"Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients: a PET\/MR study","volume":"30","author":"Marklund","year":"2021","journal-title":"Neuroimage Clin."},{"key":"2023033021451397000_64.3.460.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0342-8"},{"key":"2023033021451397000_64.3.460.26","doi-asserted-by":"crossref","unstructured":"Lin A Charney M Shenton ME Koerte IK . Chapter 29: chronic traumatic encephalopathy\u2014neuroimaging biomarkers. In: Hainline B Stern RA , eds. Handbook of Clinical Neurology. Vol 158. Elsevier; 2018:309\u2013322.","DOI":"10.1016\/B978-0-444-63954-7.00029-X"},{"key":"2023033021451397000_64.3.460.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.094029"},{"key":"2023033021451397000_64.3.460.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.224113"},{"key":"2023033021451397000_64.3.460.29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11307-017-1143-1","article-title":"MAO-B inhibitors do not block in\u00a0vivo flortaucipir ([18F]-AV-1451) binding","volume":"20","author":"Hansen","year":"2018","journal-title":"Mol Imaging Biol."},{"key":"2023033021451397000_64.3.460.30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00259-019-04305-8","article-title":"Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in\u00a0vivo imaging","volume":"46","author":"Murugan","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023033021451397000_64.3.460.31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mds.27271","article-title":"The tau positron\u2010emission tomography tracer AV\u20101451 binds with similar affinities to tau fibrils and monoamine oxidases","volume":"33","author":"Vermeiren","year":"2018","journal-title":"Mov Disord."},{"key":"2023033021451397000_64.3.460.32","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1021\/acschemneuro.9b00326","article-title":"Identification of AV-1451 as a weak, nonselective inhibitor of monoamine oxidase","volume":"10","author":"Drake","year":"2019","journal-title":"ACS Chem Neurosci."},{"key":"2023033021451397000_64.3.460.33","doi-asserted-by":"crossref","unstructured":"Ekblom J Jossan SS Oreland L Walum E Aquilonius SM . Reactive gliosis and monoamine oxidase B. In: Amine Oxidases: Function and Dysfunction. Springer; 1994:253\u2013258.","DOI":"10.1007\/978-3-7091-9324-2_33"},{"key":"2023033021451397000_64.3.460.34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00401-021-02322-2","article-title":"Altered oligodendroglia and astroglia in chronic traumatic encephalopathy","volume":"142","author":"Chancellor","year":"2021","journal-title":"Acta Neuropathol (Berl)."},{"key":"2023033021451397000_64.3.460.35","doi-asserted-by":"crossref","first-page":"fcac019","DOI":"10.1093\/braincomms\/fcac019","article-title":"Characterization of neuroinflammatory positron emission tomography biomarkers in chronic traumatic encephalopathy","volume":"4","author":"Varlow","year":"2022","journal-title":"Brain Commun."},{"key":"2023033021451397000_64.3.460.36","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.neubiorev.2017.08.023","article-title":"Psychiatric phenotypes in chronic traumatic encephalopathy","volume":"83","author":"Mahar","year":"2017","journal-title":"Neurosci Biobehav Rev."},{"key":"2023033021451397000_64.3.460.37","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.11.1209"},{"key":"2023033021451397000_64.3.460.38","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","article-title":"Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer\u2019s disease and other tauopathies","volume":"46","author":"Kroth","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023033021451397000_64.3.460.39","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/jamaneurol.2020.2526","article-title":"Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy","volume":"77","author":"Brendel","year":"2020","journal-title":"JAMA Neurol."},{"key":"2023033021451397000_64.3.460.40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/mds.28867","article-title":"In vivo 18F\u2010APN\u20101607 tau positron emission tomography imaging in MAPT mutations: cross\u2010sectional and longitudinal findings","volume":"37","author":"Zhou","year":"2022","journal-title":"Mov Disord."},{"key":"2023033021451397000_64.3.460.41","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.28672","article-title":"Clinical utility of 18F-APN-1607 tau PET imaging in patients with progressive supranuclear palsy","volume":"36","author":"Li","year":"2021","journal-title":"Mov Disord."},{"key":"2023033021451397000_64.3.460.42","doi-asserted-by":"crossref","first-page":"789054","DOI":"10.3389\/fnagi.2021.789054","article-title":"18F-APN-1607 tau positron emission tomography imaging for evaluating disease progression in Alzheimer\u2019s disease","volume":"13","author":"Xu","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"2023033021451397000_64.3.460.43","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00401-021-02294-3","article-title":"Cryo-EM structures of tau filaments from Alzheimer\u2019s disease with PET ligand APN-1607","volume":"141","author":"Shi","year":"2021","journal-title":"Acta Neuropathol (Berl)."},{"key":"2023033021451397000_64.3.460.44","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1021\/acschemneuro.1c00536","article-title":"Dissecting the binding profile of PET tracers to corticobasal degeneration tau fibrils","volume":"12","author":"Zhou","year":"2021","journal-title":"ACS Chem Neurosci."},{"key":"2023033021451397000_64.3.460.45","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/bpa.12867","article-title":"Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy","volume":"30","author":"Cherry","year":"2020","journal-title":"Brain Pathol."},{"key":"2023033021451397000_64.3.460.46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jlcr.3890","article-title":"Radiosynthesis and quality control testing of the tau imaging positron emission tomography tracer [18F] PM\u2010PBB3 for clinical applications","volume":"64","author":"Kawamura","year":"2021","journal-title":"J Labelled Comp Radiopharm."},{"key":"2023033021451397000_64.3.460.47","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1021\/acschemneuro.0c00801","article-title":"Radiosynthesis, in\u00a0vitro and in\u00a0vivo evaluation of [18F]CBD-2115 as a first-in-class radiotracer for imaging 4R-tauopathies","volume":"12","author":"Lindberg","year":"2021","journal-title":"ACS Chem Neurosci."},{"key":"2023033021451397000_64.3.460.48","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1021\/acschemneuro.0c00340","article-title":"Cryptic sites in tau fibrils explain the preferential binding of the AV-1451 PET tracer toward Alzheimer\u2019s tauopathy","volume":"12","author":"Murugan","year":"2021","journal-title":"ACS Chem Neurosci."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.122.264404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T04:46:54Z","timestamp":1680238014000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.122.264404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,2]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.2967\/jnumed.122.264404"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.122.264404","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]}}}